[144] uniQure N.V. SEC Filing

Rhea-AI Filing Summary

Form 144 notice by uniQure N.V. (QURE) reporting a proposed sale of 3,000 ordinary shares through Citigroup Global Markets on 09/24/2025 with an aggregate market value of $120,000.00. The filing lists total shares outstanding as 54,866,930. The securities were acquired and are to be sold on 09/24/2025 as the result of a stock option exercise and sale pursuant to a Rule 10b5-1 plan, and payment for the acquisition was in cash. The filer indicates no securities sold by the same person in the past three months and includes the standard representation that the person does not possess undisclosed material adverse information.

Insights

Securities Compliance Analyst

TL;DR: Routine Rule 144 notice documenting a 10b5-1 plan sale of 3,000 shares via Citigroup.

The filing records a proposed sale under Rule 144 of 3,000 ordinary shares of uniQure N.V. executed through Citigroup Global Markets on 09/24/2025. The acquisition and sale are reported as occurring on the same date via a stock option exercise tied to a Rule 10b5-1 plan, with cash payment noted. The filer reports no other sales in the past three months and includes the customary representation regarding material nonpublic information. From a compliance perspective, the notice contains the key elements required for a Form 144: class of security, broker, amount, value, outstanding shares, and acquisition details.

Corporate Governance Specialist

TL;DR: Disclosure is procedural and limited to the mechanics of a planned sale under an established trading plan.

The form documents the mechanics of the transaction—number of shares, broker, acquisition method, and sale date—and states the existence of a 10b5-1 arrangement by describing the transaction as an exercise and sale pursuant to such a plan. The filing provides no additional context about the identity of the selling person beyond the standard representation or about any changes in ownership beyond this notice. For governance review, the form supplies required transactional facts but no further narrative or material disclosures.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
ORDINARY SHARES	CITIGROUP GLOBAL MARKETS 390 GREENWICH ST NEW YORK NY 10013	3000	120000.00	54866930	09/24/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ORDINARY SHARES	09/24/2025	STOCK OPTION EXERCISE AND SALE PURSUANT TO 10B51 PLAN	UNIQURE NV			3000	09/24/2025	CASH

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does uniQure's (QURE) Form 144 filed here report?

The Form 144 reports a proposed sale of 3,000 ordinary shares of uniQure through Citigroup Global Markets on 09/24/2025 with an aggregate market value of $120,000.00.

How were the shares acquired according to the filing?

The filing states the shares were acquired on 09/24/2025 via a stock option exercise and sale pursuant to a Rule 10b5-1 plan, with payment in cash.

Does the Form 144 show other sales by the same person in the past three months?

The filing indicates Nothing to Report for securities sold during the past three months by the person for whose account these securities are to be sold.

What is the total number of uniQure shares outstanding reported in the notice?

The Form 144 lists 54,866,930 shares outstanding.

Which broker is handling the proposed sale on this Form 144?

The broker listed is Citigroup Global Markets, located at 390 Greenwich St, New York, NY 10013.